We analyzed the expression of FRα in CRC cell lines compared to the FRα-overexpressing ovarian cancer cell line, SK-OV-3; a choriocarcinoma cell line, JAR; and in patient-derived xenografts (n=16; PDX). This evidence concerns the gene FOLR1 and ovarian cancer.